berkeley and has served on the clinical faculties of harvard medical school and the university of californiathese men don't get the help that they need. that's extremely detrimental not only for these men, but for their children during these critical first few years," says courtenay. "a father's depression has a long-term impact on the psychological, social, and behavioral development of his kids." he adds, "we see this in children as young as 2, all the way through adolescence, and into young adulthood."in his book dying to be men (routledge), courtenay talks about some of the ineffective ways men cope with depression, which often compounds their risks and worsens their depression. he says, "men's way of coping with depression often includes an increased use of alcohol or other drugs, or impulsiveness and taking risks - like reckless driving, gambling or extramarital sex." although testosterone supplements are tempting to consider, courtenay says they could end up making things worse for a man's family. better strategies include exercise, improving sleep and talk therapy, which has been fou

that was harvard medical school.rl jasmine who eventually is today my fiancee and planning a wedding for next year. so, even though i've gone through this journey, i mean, it's not lost on me how unbelievable this ride has been and how lucky i am to be here. be patient with difficult times and even when things may be getting worse for a little while, just be patient and stick to it. >> so many incredible real stories of survival. so many good doctors. "the good doctor" airs monday, 10:00, 9:00 p.m. central. and meet tv's newest superhero, dr. shaun murphy, right here on abc. that's our show tonight. i'm elizabeth vargas. thanks so much for joining us. have a great night.

understanding -- >> my name is aaron, i am an associate professor of medicine at harvard medical school. i run the program on regulation therapeutics in law which is an internet engine in her disciplinary program between pharmaceuticals and laws and regulations and clinical outcomes. we are the largest independent academic group in the country focusing on this matter. it's my pleasure to be here and i want to thank american university for putting together such great program and the american society of law medicine and ethics and other sponsors of this conference which have been a fantastic conversation. we spent a lot of time talking about the future of healthcare policymaking. industry plays an important role in bringing these products forward, but in recent years, drug crisis has continued to rise which has made some of these breakthroughs unaffordable for patients and leading directly to bad consequences when patients are unable to afford the medication as well as driving healthcare spending with spending on pharmaceutical by some estimates making up 20% of healthcare spending overal

. >> i am from harvard medical school on november 27 the supreme court heard the case is in short form in which the existence of the patent trial and appeals court is being challenged this is within the u.s. pt go with those drug companies to challenge the integrity of the patents of those drug companies if it is found to be unconstitutional and is basically overturned that would be for the generic companies to challenge their patent. and will probably be deuce the efficiency that they can get to the market. >> i am aware of it. >> also one of the things about the patent trial is it isn't only generic manufacturers to see that consumer group with those patents related to hepatitis c drugs that lacked the requirements that we may require. so those issues to allow pharmaceutical manufacturers to expand that exclusivity with those basic boundaries and that is the challenge them. without having to rely so it is important coming up with another avenue to address this problem will take a different strategies in it isn't a magic bullet but it is the effective strategy and it would be interest

resume than dolled trump could could hope would have psychiatry as the lance dodes a former harvard medical school professor says trump's sociopathic characteristics are undeniable and his speech and behavior show signs of significant mental derangement absolutely i absolutely agree but then why does our corporate media. ford on him endlessly in a lot of ways i mean yes they criticize him a lot but they get a lot of ways they're fawning on him especially when it comes to the do our war games to our bombing and when he started bombing syria they all cheered at all and they they cheer on most of his belligerence with north korea yeah every once in awhile there go all he doesn't know what to do and but most of the time with our war games it i mean like i've said many times the democrats helped confirm general mad dog mattis is secretary of defense ninety eight to one and the one the one that voted against i don't know i'm sure it was think it was like the. guy guarding the door you know was like a janitor walked in that he was the one that was i r o a don't don't put that guy in charge of the defense

resume than doll trump could could i hope you have psychiatry as to lance dodes a former harvard medical school professor says trump's sociopathic characteristics are undeniable and his speech and behavior show signs of significant mental derangement absolutely i absolutely agree. but then why does our corporate media. fall on him endlessly in a lot of ways i mean yes they criticize him a lot but they in a lot of ways they're fawning on him especially when it comes to the to our board games to our bombing and when he started bombing syria they all cheered at all and they they cheer on most of his belligerence with north korea yeah every once in awhile there go all he doesn't know what to do and but most of the time with our war games it i mean like i've said many times the democrats helped confirm general mad dog mattis is secretary of defense ninety eight to one and the one the one that voted against i don't know i'm sure it was think it was like the. guy guarding the door you know was like a janitor walked in there he was the one that was i r o a don't don't put that guy in charge of the defe

. >> my name is craig and i'm from harvard medical school, and my question is actually related to thelast question. on november 27 the supreme court will hear a case referred to in short form as oil states, and which the existence of the patent trial and appeals board is being challenged. this this is a board within theo that allows generic drug companies to challenge the integrity of patents of brand-name drug companies. if this board is basically found to be unconstitutionally developed and is basically overturned, it will eliminate that pathway for generic companies to challenge ran name patents, -- brand name patents and probably will reduce the efficiency with which generic companies can get to the market. so i wonder if either of you are following this case and if you might have any comments? >> i'm aware of it. dr. kesselheim has followed it in detail so i will defer to him on this question. >> i would actually also add one of the nice things about patent trial on and appeals board is it not only allows generic manufacturers to chomp but he would let any party to bring a challe

and harvard medical school researchers is ink.k changes color according to biochemistry. they are hoping it would help people like diabetes better monitor their health. ahead at 6:00 -- "7 on your side" consumer alert. the digital device caught listening to your every word. plus parents leaving a corn maze with the little boy still inside. how long it took for them to realize the child was not with them. the man that leapt out of a comic store bookstore in a single bound only to remember it was two stories up. what he was running away from tonight at 6:00. larry: well; take a look at the latest fashion for your dog. that is right. furry friends strutting stuff on the catwalk in beverly hills. the k9 courture 2018 spring summer collection. the dogs on the runway looking for the forever home. nancy: i love it. some dogs are walking and others have to be carryied. nancy: you may be thinking what you will dress up for on halloween. if you are thinking what about the candy? larry: that is my favorite part. we have the list of the popul

she's a professor of psychobiology at harvard medical school. and dr.rew kolodny-- he's co-director of opioid policy research at brandeis university's heller school and is executive director of "physicians for responsible opioid prescribing," a group dedicated to reducing the over- prescription of painkillers. welcome to you both to the newshour. >> thank you, delighted to be here. >> andrew kolodny i would like to start with you, i wonder if you could give me your reaction to the president's initiative today? >> i'm disappointed. we heard from the president last august that he considered the opioid crisis to be an emergency. back in august i would have expected the president to announce what he was going to do about the problem and to begin taking action. if you call a problem an emergency, you expect to see immediate action to address it. and then months went by and today we heard again that he considers this an emergency. he's giving it an official des ig nation as a public health emergency but we're still not really receiving a detailed plan about t

peter grinspoon, on staff at mass general teaches at harvard medical school, former opioid addict clean for ten years and wrote "free refills: a doctor confronts his addiction "and an oral surgeon and add jumpjunct minnesota school of dentistry. her history spurred by her brother's addiction and abuse. and chief medical examining who retired after 20 years. all these doctors got real and held nothing back. let's hear more of their eye-opening conversation. >> how did doctors become major suppliers, get tricked into thinking pain is best treated with addicted medications? >> i think betrayed by an academic physician and because i'm one i feel i can say that. folks who supposed to be our thought leaders. hired from pharma and others, told them sa prescribes more opioids is supported by science. practicing evidence-based science. and a whole group of doctors, myself included, absolutely believed this myth. believed it was based in science, patients couldn't get addicted and worked for chronic pain and now we are seeing the results. >> there's no one who could convince me otherwise. yes, we

my name is aaron and i'm an associate professor of medicine at harvard medical school

riskge education poster according to harvard medical school professor dr. edward clark. in his 1873 book sex and education clerk warned that women using their brains would shrink their uteruses. i wish i thought of this when i was a high school principal studying calculus provides birth control. proportionally more african-american families embraced academic opportunities for girls hoping to protect their daughters from sexual harassment in the postwar south. many college-educated women did have fewer children because they married later if at all. of black and white middle-class women embraced social activism. the 1890's in small towns and cities these women organized andegated clubs federations. they expended sewing circles and church of salaries to find common cause and causes such as playground, kindergartens, sewer housing and systems. college graduates formed the initially all white american association of university women. which funded research to challenge dr. clark's thesis and supported marie curie's experiments. the daughters of the american revolution establish

my name is aaron and i'm an associate professor of medicine at harvard medical school and hospital. i run the program on regulation, therapeutics and law there which is an interdisciplinary research program that focuses on intersections pharmaceuticals and laws and regulation and clinical outcomes where they are the largest independent academic group on the country focusing on these matters. is my pleasure to be here and i want to thank american university for putting together such a great program and the american society of law and method and ethics and other sponsors of this conference has been a pretested conversation. so, we spent a lot of time talking about the future of healthcare policymaking in our lunch session will be focused on one particular area which is the pharmaceutical marketplace. pharmaceutical prescription drugs are some of the most effective and most cost-effective interventions that we have in medicine. industry plays an important role in bringing these products forward but in recent years drug prices have continued to rise which has made some of these breakthr

reported on the pain experienced by unborn children by a pediatrician who held an appointment at harvard medical school. as the doctor testifiedf the fetus is beyond 20 weeks of gestation, i assume there will be pain caused to the fetus and i believe it will be severe and excruciating pain. congress has the power and responsibility to acknowledge these developments in our understanding of unborn children feeling pain prohibiting bortion after 20 weeks which scientific evidence shows the unborn can experience suffering. in fact, the nonpartisan congressional budget office is so confident that this bill would save lives that it took the rare step of estimating the number of lives that would be saved if this bill is enacted. the c.b.o. conservatively estimates that this bill would save over 2,000 lives each year giving america the gift of thousands more children with all the wonder address the house human gifts they will bring to the world in so many amazing forms for generations to come. i thank trent franks for introducing this vital legislation. i urge my colleagues to support this bill, both on behalf

he leads much of the health care policy coming out of harvard medical school but also sits on harvard's benefits committee, where he learned why markets are not always efficient. is that fair to say? [laughter] , he also serves on cbo's panel of health advisors, members of the massachusetts health connector board of directors and vice chair of met pack. we had the fortune of having mike serve on one of our advisory boards. he is one of the pioneers of insurance design and go to researcher for evaluating health care in organizations. join me in welcoming mike to the panel. [applause] mike: i am thrilled to be here. nice in herays introductions. tremendous to see all of you here. i am going to talk broadly about payment reform, benefit design because bob was going to talk about the budget, i want to start with comments about the budget. the quiz question is, what do these decades have in common? if the answer is in everyone, spending growth exceeded income growth. 1970's, we were 2% faster. in the 1990's, considered a very good decade for health-care spending growth, we had it only exceed

and he leads much of the health care policy work coming out of harvard medical school, he also sits on harvard's benefit's committee, where he learns firsthand why markets are not always efficient. is that fair to say? >> he also serves on cbo's panel of health advisers. a member of the massachusetts health connecter board of directors and vice chair of medpac. we have the fortune of having him serve on our advisory board. he's one of the pioneers of value based insurance design. and the go to researcher for medicare programs. please invite me in joining mike to the panel. >> i am thrilled to be here. nicum always does a good job, nancy is too nice in her introductions. it's nice to see you all here. i'm going to talk broadly about payment reform, a little bit of benefit design. because bob was going to talk about the budget, i want to start with some comments about the budget. the quiz question. i'm not sure boch would have had this, what do these decades have in common. and the answer is, in every one health care spending growth exceeded health care growth. by varying amounts in the

understanding -- >> my name is aaron, i am an associate professor of medicine at harvard medical school. i run the program on regulation therapeutics in law which is an internet engine in her disciplinary program between pharmaceuticals and laws and regulations and clinical outcomes. we arehe

my name is aaron and i'm an associate professor of medicine at harvard medical school and hospital. i run the program on regulation, therapeutics and law there which is an interdisciplinary research program that focuses on intersections pharmaceuticals and laws and regulation and clinical outcomes where they are the largest independent academic group on the country focusing on these matters. is my pleasure to be here and i want to thank american university for putting together such a great program and the american society of law and method and ethics and other sponsors of this conference has been a pretested conversation. so, we spent a lot of time talking about the future of healthcare policymaking in our lunch session will be focused on one particular area which is the pharmaceutical marketplace. pharmaceutical prescription drugs are some of the most effective and most cost-effective interventions that we have in medicine. industry plays an important role in bringing these products forward but in recent years drug prices have continued to rise which m